We undertook the present study to gain further insight into the expression pattern of MMP-9 in invasive breast cancer and its relationship with clinicopathological characteristics, lymph vessel density (LMVD), tumor metastasis potential and estrogen receptor (ER), progesterone receptor (PR), and HER2/neu status. The gene discussed is ERBB2; the disease is invasive breast carcinoma.